table of content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Needle-Free Drug Delivery Market Size Analysis from 2022 to 2027
1.5.1 Global Needle-Free Drug Delivery Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Needle-Free Drug Delivery Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Needle-Free Drug Delivery Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Needle-Free Drug Delivery Industry Impact
Chapter 2 Global Needle-Free Drug Delivery Competition by Types, Applications, and Top Regions and Countries
2.1 Global Needle-Free Drug Delivery (Volume and Value) by Type
2.1.1 Global Needle-Free Drug Delivery Consumption and Market Share by Type (2016-2021)
2.1.2 Global Needle-Free Drug Delivery Revenue and Market Share by Type (2016-2021)
2.2 Global Needle-Free Drug Delivery (Volume and Value) by Application
2.2.1 Global Needle-Free Drug Delivery Consumption and Market Share by Application (2016-2021)
2.2.2 Global Needle-Free Drug Delivery Revenue and Market Share by Application (2016-2021)
2.3 Global Needle-Free Drug Delivery (Volume and Value) by Regions
2.3.1 Global Needle-Free Drug Delivery Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Needle-Free Drug Delivery Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Needle-Free Drug Delivery Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Needle-Free Drug Delivery Consumption by Regions (2016-2021)
4.2 North America Needle-Free Drug Delivery Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Needle-Free Drug Delivery Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Needle-Free Drug Delivery Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Needle-Free Drug Delivery Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Needle-Free Drug Delivery Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Needle-Free Drug Delivery Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Needle-Free Drug Delivery Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Needle-Free Drug Delivery Sales, Consumption, Export, Import (2016-2021)
4.10 South America Needle-Free Drug Delivery Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Needle-Free Drug Delivery Market Analysis
5.1 North America Needle-Free Drug Delivery Consumption and Value Analysis
5.1.1 North America Needle-Free Drug Delivery Market Under COVID-19
5.2 North America Needle-Free Drug Delivery Consumption Volume by Types
5.3 North America Needle-Free Drug Delivery Consumption Structure by Application
5.4 North America Needle-Free Drug Delivery Consumption by Top Countries
5.4.1 United States Needle-Free Drug Delivery Consumption Volume from 2016 to 2021
5.4.2 Canada Needle-Free Drug Delivery Consumption Volume from 2016 to 2021
5.4.3 Mexico Needle-Free Drug Delivery Consumption Volume from 2016 to 2021
Chapter 6 East Asia Needle-Free Drug Delivery Market Analysis
6.1 East Asia Needle-Free Drug Delivery Consumption and Value Analysis
6.1.1 East Asia Needle-Free Drug Delivery Market Under COVID-19
6.2 East Asia Needle-Free Drug Delivery Consumption Volume by Types
6.3 East Asia Needle-Free Drug Delivery Consumption Structure by Application
6.4 East Asia Needle-Free Drug Delivery Consumption by Top Countries
6.4.1 China Needle-Free Drug Delivery Consumption Volume from 2016 to 2021
6.4.2 Japan Needle-Free Drug Delivery Consumption Volume from 2016 to 2021
6.4.3 South Korea Needle-Free Drug Delivery Consumption Volume from 2016 to 2021
Chapter 7 Europe Needle-Free Drug Delivery Market Analysis
7.1 Europe Needle-Free Drug Delivery Consumption and Value Analysis
7.1.1 Europe Needle-Free Drug Delivery Market Under COVID-19
7.2 Europe Needle-Free Drug Delivery Consumption Volume by Types
7.3 Europe Needle-Free Drug Delivery Consumption Structure by Application
7.4 Europe Needle-Free Drug Delivery Consumption by Top Countries
7.4.1 Germany Needle-Free Drug Delivery Consumption Volume from 2016 to 2021
7.4.2 UK Needle-Free Drug Delivery Consumption Volume from 2016 to 2021
7.4.3 France Needle-Free Drug Delivery Consumption Volume from 2016 to 2021
7.4.4 Italy Needle-Free Drug Delivery Consumption Volume from 2016 to 2021
7.4.5 Russia Needle-Free Drug Delivery Consumption Volume from 2016 to 2021
7.4.6 Spain Needle-Free Drug Delivery Consumption Volume from 2016 to 2021
7.4.7 Netherlands Needle-Free Drug Delivery Consumption Volume from 2016 to 2021
7.4.8 Switzerland Needle-Free Drug Delivery Consumption Volume from 2016 to 2021
7.4.9 Poland Needle-Free Drug Delivery Consumption Volume from 2016 to 2021
Chapter 8 South Asia Needle-Free Drug Delivery Market Analysis
8.1 South Asia Needle-Free Drug Delivery Consumption and Value Analysis
8.1.1 South Asia Needle-Free Drug Delivery Market Under COVID-19
8.2 South Asia Needle-Free Drug Delivery Consumption Volume by Types
8.3 South Asia Needle-Free Drug Delivery Consumption Structure by Application
8.4 South Asia Needle-Free Drug Delivery Consumption by Top Countries
8.4.1 India Needle-Free Drug Delivery Consumption Volume from 2016 to 2021
8.4.2 Pakistan Needle-Free Drug Delivery Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Needle-Free Drug Delivery Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Needle-Free Drug Delivery Market Analysis
9.1 Southeast Asia Needle-Free Drug Delivery Consumption and Value Analysis
9.1.1 Southeast Asia Needle-Free Drug Delivery Market Under COVID-19
9.2 Southeast Asia Needle-Free Drug Delivery Consumption Volume by Types
9.3 Southeast Asia Needle-Free Drug Delivery Consumption Structure by Application
9.4 Southeast Asia Needle-Free Drug Delivery Consumption by Top Countries
9.4.1 Indonesia Needle-Free Drug Delivery Consumption Volume from 2016 to 2021
9.4.2 Thailand Needle-Free Drug Delivery Consumption Volume from 2016 to 2021
9.4.3 Singapore Needle-Free Drug Delivery Consumption Volume from 2016 to 2021
9.4.4 Malaysia Needle-Free Drug Delivery Consumption Volume from 2016 to 2021
9.4.5 Philippines Needle-Free Drug Delivery Consumption Volume from 2016 to 2021
9.4.6 Vietnam Needle-Free Drug Delivery Consumption Volume from 2016 to 2021
9.4.7 Myanmar Needle-Free Drug Delivery Consumption Volume from 2016 to 2021
Chapter 10 Middle East Needle-Free Drug Delivery Market Analysis
10.1 Middle East Needle-Free Drug Delivery Consumption and Value Analysis
10.1.1 Middle East Needle-Free Drug Delivery Market Under COVID-19
10.2 Middle East Needle-Free Drug Delivery Consumption Volume by Types
10.3 Middle East Needle-Free Drug Delivery Consumption Structure by Application
10.4 Middle East Needle-Free Drug Delivery Consumption by Top Countries
10.4.1 Turkey Needle-Free Drug Delivery Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Needle-Free Drug Delivery Consumption Volume from 2016 to 2021
10.4.3 Iran Needle-Free Drug Delivery Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Needle-Free Drug Delivery Consumption Volume from 2016 to 2021
10.4.5 Israel Needle-Free Drug Delivery Consumption Volume from 2016 to 2021
10.4.6 Iraq Needle-Free Drug Delivery Consumption Volume from 2016 to 2021
10.4.7 Qatar Needle-Free Drug Delivery Consumption Volume from 2016 to 2021
10.4.8 Kuwait Needle-Free Drug Delivery Consumption Volume from 2016 to 2021
10.4.9 Oman Needle-Free Drug Delivery Consumption Volume from 2016 to 2021
Chapter 11 Africa Needle-Free Drug Delivery Market Analysis
11.1 Africa Needle-Free Drug Delivery Consumption and Value Analysis
11.1.1 Africa Needle-Free Drug Delivery Market Under COVID-19
11.2 Africa Needle-Free Drug Delivery Consumption Volume by Types
11.3 Africa Needle-Free Drug Delivery Consumption Structure by Application
11.4 Africa Needle-Free Drug Delivery Consumption by Top Countries
11.4.1 Nigeria Needle-Free Drug Delivery Consumption Volume from 2016 to 2021
11.4.2 South Africa Needle-Free Drug Delivery Consumption Volume from 2016 to 2021
11.4.3 Egypt Needle-Free Drug Delivery Consumption Volume from 2016 to 2021
11.4.4 Algeria Needle-Free Drug Delivery Consumption Volume from 2016 to 2021
11.4.5 Morocco Needle-Free Drug Delivery Consumption Volume from 2016 to 2021
Chapter 12 Oceania Needle-Free Drug Delivery Market Analysis
12.1 Oceania Needle-Free Drug Delivery Consumption and Value Analysis
12.2 Oceania Needle-Free Drug Delivery Consumption Volume by Types
12.3 Oceania Needle-Free Drug Delivery Consumption Structure by Application
12.4 Oceania Needle-Free Drug Delivery Consumption by Top Countries
12.4.1 Australia Needle-Free Drug Delivery Consumption Volume from 2016 to 2021
12.4.2 New Zealand Needle-Free Drug Delivery Consumption Volume from 2016 to 2021
Chapter 13 South America Needle-Free Drug Delivery Market Analysis
13.1 South America Needle-Free Drug Delivery Consumption and Value Analysis
13.1.1 South America Needle-Free Drug Delivery Market Under COVID-19
13.2 South America Needle-Free Drug Delivery Consumption Volume by Types
13.3 South America Needle-Free Drug Delivery Consumption Structure by Application
13.4 South America Needle-Free Drug Delivery Consumption Volume by Major Countries
13.4.1 Brazil Needle-Free Drug Delivery Consumption Volume from 2016 to 2021
13.4.2 Argentina Needle-Free Drug Delivery Consumption Volume from 2016 to 2021
13.4.3 Columbia Needle-Free Drug Delivery Consumption Volume from 2016 to 2021
13.4.4 Chile Needle-Free Drug Delivery Consumption Volume from 2016 to 2021
13.4.5 Venezuela Needle-Free Drug Delivery Consumption Volume from 2016 to 2021
13.4.6 Peru Needle-Free Drug Delivery Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Needle-Free Drug Delivery Consumption Volume from 2016 to 2021
13.4.8 Ecuador Needle-Free Drug Delivery Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Needle-Free Drug Delivery Business
14.1 Endo Pharmaceuticals
14.1.1 Endo Pharmaceuticals Company Profile
14.1.2 Endo Pharmaceuticals Needle-Free Drug Delivery Product Specification
14.1.3 Endo Pharmaceuticals Needle-Free Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Antares Pharma
14.2.1 Antares Pharma Company Profile
14.2.2 Antares Pharma Needle-Free Drug Delivery Product Specification
14.2.3 Antares Pharma Needle-Free Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 Inovio Pharmaceuticals
14.3.1 Inovio Pharmaceuticals Company Profile
14.3.2 Inovio Pharmaceuticals Needle-Free Drug Delivery Product Specification
14.3.3 Inovio Pharmaceuticals Needle-Free Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Valeritas
14.4.1 Valeritas Company Profile
14.4.2 Valeritas Needle-Free Drug Delivery Product Specification
14.4.3 Valeritas Needle-Free Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 PharmaJet
14.5.1 PharmaJet Company Profile
14.5.2 PharmaJet Needle-Free Drug Delivery Product Specification
14.5.3 PharmaJet Needle-Free Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 3M
14.6.1 3M Company Profile
14.6.2 3M Needle-Free Drug Delivery Product Specification
14.6.3 3M Needle-Free Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 Akra Dermojet
14.7.1 Akra Dermojet Company Profile
14.7.2 Akra Dermojet Needle-Free Drug Delivery Product Specification
14.7.3 Akra Dermojet Needle-Free Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Consort Medical
14.8.1 Consort Medical Company Profile
14.8.2 Consort Medical Needle-Free Drug Delivery Product Specification
14.8.3 Consort Medical Needle-Free Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 PenJet
14.9.1 PenJet Company Profile
14.9.2 PenJet Needle-Free Drug Delivery Product Specification
14.9.3 PenJet Needle-Free Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 BD
14.10.1 BD Company Profile
14.10.2 BD Needle-Free Drug Delivery Product Specification
14.10.3 BD Needle-Free Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.11 Med Immune
14.11.1 Med Immune Company Profile
14.11.2 Med Immune Needle-Free Drug Delivery Product Specification
14.11.3 Med Immune Needle-Free Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Needle-Free Drug Delivery Market Forecast (2022-2027)
15.1 Global Needle-Free Drug Delivery Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Needle-Free Drug Delivery Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Needle-Free Drug Delivery Value and Growth Rate Forecast (2022-2027)
15.2 Global Needle-Free Drug Delivery Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Needle-Free Drug Delivery Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Needle-Free Drug Delivery Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Needle-Free Drug Delivery Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Needle-Free Drug Delivery Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Needle-Free Drug Delivery Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Needle-Free Drug Delivery Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Needle-Free Drug Delivery Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Needle-Free Drug Delivery Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Needle-Free Drug Delivery Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Needle-Free Drug Delivery Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Needle-Free Drug Delivery Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Needle-Free Drug Delivery Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Needle-Free Drug Delivery Consumption Forecast by Type (2022-2027)
15.3.2 Global Needle-Free Drug Delivery Revenue Forecast by Type (2022-2027)
15.3.3 Global Needle-Free Drug Delivery Price Forecast by Type (2022-2027)
15.4 Global Needle-Free Drug Delivery Consumption Volume Forecast by Application (2022-2027)
15.5 Needle-Free Drug Delivery Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
